These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18174859)

  • 21. Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.
    Spriet I; Brüggemann RJ; Annaert P; Meersseman P; Van Wijngaerden E; Lagrou K; Willems L
    Ther Drug Monit; 2013 Feb; 35(1):141-3. PubMed ID: 23296095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voriconazole plasma monitoring.
    Pasqualotto AC; Shah M; Wynn R; Denning DW
    Arch Dis Child; 2008 Jul; 93(7):578-81. PubMed ID: 18252755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis.
    Sugar AM; Liu XP
    Antimicrob Agents Chemother; 2001 Feb; 45(2):601-4. PubMed ID: 11158762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Keratomycosis in a dog treated with topical 1% voriconazole solution.
    Grundon RA; O'Reilly A; Muhlnickel C; Hardman C; Stanley RG
    Vet Ophthalmol; 2010 Sep; 13(5):331-5. PubMed ID: 20840112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
    González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M
    J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of voriconazole in candida retinitis.
    Varma D; Thaker HR; Moss PJ; Wedgwood K; Innes JR
    Eye (Lond); 2005 Apr; 19(4):485-7. PubMed ID: 15105823
    [No Abstract]   [Full Text] [Related]  

  • 27. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
    Lutsar I; Roffey S; Troke P
    Clin Infect Dis; 2003 Sep; 37(5):728-32. PubMed ID: 12942409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voriconazole stability in cement spacers.
    Denes E; Fiorenza F; Saint-Marcoux F; Megherbi M; Dupon M; Weinbreck P
    Med Mal Infect; 2012 Nov; 42(11):567-8. PubMed ID: 23044087
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of lung scedosporiosis successfully treated with monitoring of plasma voriconazole concentration level].
    Ogata R; Hagiwara E; Shiihara J; Ogura T; Takahashi H; Kamei K
    Nihon Kokyuki Gakkai Zasshi; 2011 May; 49(5):388-92. PubMed ID: 21688649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An alternative approach to determine oral bioavailability of drugs that follow Michaelis-Menten elimination: a case study with voriconazole.
    Verlindo de Araujo B; Farias da Silva C; Costa TD
    Pharmacology; 2010; 86(3):163-7. PubMed ID: 20714206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
    Uriz J; de Andoin NG; Calvo C; Landa J; Onate E; Nogues A; Guerrero R
    Pediatr Infect Dis J; 2007 Oct; 26(10):971-2. PubMed ID: 17901816
    [No Abstract]   [Full Text] [Related]  

  • 32. Random plasma concentrations of voriconazole decline over time.
    Mulanovich V; Lewis RE; Raad II; Kontoyiannis DP
    J Infect; 2007 Nov; 55(5):e129-30. PubMed ID: 17804077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh).
    Flammer K; Nettifee Osborne JA; Webb DJ; Foster LE; Dillard SL; Davis JL
    Am J Vet Res; 2008 Jan; 69(1):114-21. PubMed ID: 18167096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of therapeutic drug monitoring of voriconazole in a pediatric population.
    Brüggemann RJ; van der Linden JW; Verweij PE; Burger DM; Warris A
    Pediatr Infect Dis J; 2011 Jun; 30(6):533-4. PubMed ID: 21127454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral voriconazole dose in children: one size does not fit all.
    Goutelle S; Larcher R; Padoin C; Mialou V; Bleyzac N
    Clin Infect Dis; 2010 Oct; 51(7):870; author reply 871. PubMed ID: 20809842
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole.
    Craiglow B; Hinds G; Antaya R; Girardi M
    Pediatr Dermatol; 2009; 26(4):493-5. PubMed ID: 19689543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinician ordering practices for voriconazole therapeutic drug monitoring: experiences of a referral laboratory.
    Miyakis S; van Hal SJ; Solvag CJ; Ray J; Marriott D
    Ther Drug Monit; 2010 Oct; 32(5):661-4. PubMed ID: 20720520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.
    Moriyama B; Jarosinski PF; Figg WD; Henning SA; Danner RL; Penzak SR; Wayne AS; Walsh TJ
    Pharmacotherapy; 2013 Mar; 33(3):e19-22. PubMed ID: 23400848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.
    Troke PF; Hockey HP; Hope WW
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4782-8. PubMed ID: 21768513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
    J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.